Analyzing Long Term, End Of Study Results for Inebilizumab Treatment in NMOSD

Описание к видео Analyzing Long Term, End Of Study Results for Inebilizumab Treatment in NMOSD

Bruce Cree, MD, PhD, MAS, FAAN, the clinical research director of the UCSF Multiple Sclerosis Center, discussed findings from the end-of-study analysis assessing inebilizumab which revealed a significant reduction in attack rates among patients with NMOSD over time.

Read more: https://www.neurologylive.com/view/an...

View more NMOSD content: https://www.neurologylive.com/clinica...

Комментарии

Информация по комментариям в разработке

Похожие видео